Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Obstetrix Medical Group
Obstetrix Medical Group
Industry · 12 registered clinical trials.
Status
Trial
Phase
Started
Withdrawn
Vaginal Progesterone in Twins With Short Cervix
Premature Birth
Phase 2 / Phase 3
2014-03-01
Completed
National Prevalence and Impact of Noninvasive Prenatal Testing
Aneuploidy
—
2014-01-01
Completed
Optimal Management of Vasa Previa Study - A Retrospective Study
Vasa Previa
—
2014-01-01
Completed
Neonatal Outcome by Reason for Delivery
Preterm Delivery
—
2013-07-01
Completed
Maternal Uterine Artery Doppler Study
Maternal-Fetal Exchange
—
2012-09-01
Withdrawn
Cerclage for Prevention on Preterm Birth in Women With Placenta Previa
Premature Birth, Placenta Previa
Phase 3
2012-03-01
Completed
Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM
Preterm Delivery
Phase 2 / Phase 3
2011-10-01
Terminated
Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR
Hydrops Fetalis, Fetal Growth Retardation
—
2006-03-01
Withdrawn
fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo
Preterm Delivery, Preterm Birth
—
2005-08-01
Completed
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies
Preterm Birth
Phase 2 / Phase 3
2004-11-01
Terminated
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Fetal Membranes, Premature Rupture
Phase 4
2004-11-01
Completed
A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outc
Preterm Delivery
Phase 4
2003-11-01